Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1931 1
1945 1
1947 1
1950 1
1956 1
1961 2
1962 1
1963 1
1964 3
1965 2
1966 1
1967 3
1968 4
1969 2
1970 2
1971 2
1972 2
1973 2
1974 3
1975 3
1977 3
1979 1
1980 3
1981 6
1983 9
1984 5
1985 6
1986 1
1987 2
1988 2
1989 2
1990 7
1991 6
1992 4
1993 5
1994 5
1995 4
1996 9
1997 12
1998 9
1999 4
2000 6
2001 3
2002 4
2003 2
2004 5
2005 3
2006 3
2007 5
2008 10
2009 7
2010 6
2011 4
2012 6
2013 7
2014 3
2015 9
2016 9
2017 8
2018 12
2019 16
2020 9
2021 4
2022 6
2023 4
2024 4
2025 10
2026 8

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

301 results

Results by year

Filters applied: . Clear all
Page 1
Chronic meningococcemia.
Prista-Leão B, Almeida F, Carvalho AC, Silva S, Sarmento A. Prista-Leão B, et al. IDCases. 2019 Feb 2;15:e00502. doi: 10.1016/j.idcr.2019.e00502. eCollection 2019. IDCases. 2019. PMID: 30788217 Free PMC article.
Rarely, N. meningitidis bacteremia can be associated with a prolonged fever with or without arthritis, which we designate as chronic meningococcemia. Chronic meningococcemia is an uncommon entity, usually associated to serogroup B N. meningitidis. Diag …
Rarely, N. meningitidis bacteremia can be associated with a prolonged fever with or without arthritis, which we designate as chronic
Chronic meningococcemia: a report of 26 cases and literature review.
Lefèvre B, Poinsignon Y, Piau C, Javaugue FC, Talarmin JP, Lefebvre M, Varache N, Drouin H, Tattevin P; pour le Groupe d’Epidémiologie et Recherche en Infectiologie Clinique du Centre et de l’Ouest (GERICCO). Lefèvre B, et al. Infection. 2019 Apr;47(2):285-288. doi: 10.1007/s15010-018-1238-x. Epub 2018 Oct 19. Infection. 2019. PMID: 30341638 Review.
Chronic meningococcemia is defined by blood culture(s) positive for Neisseria meningitidis, symptoms duration > 7 days, and neither meningitis nor shock on admission. This series of 26 consecutive cases illustrates that this is a rare disease (< 5% of menin
Chronic meningococcemia is defined by blood culture(s) positive for Neisseria meningitidis, symptoms duration > 7 days, and
Chronic meningococcemia.
Tuso PJ, Ahern MJ. Tuso PJ, et al. Conn Med. 1987 Nov;51(11):698-702. Conn Med. 1987. PMID: 3123131 Review. No abstract available.
Chronic meningococcemia.
Frank ST, Gomez RM. Frank ST, et al. Mil Med. 1968 Nov;133(11):918-20. Mil Med. 1968. PMID: 4977133 No abstract available.
[Chronic meningococcemia].
Martínez JV, Verbanaz SC, Jordán R, Enríquez N, Efrón ED. Martínez JV, et al. Medicina (B Aires). 2008;68(4):298-300. Medicina (B Aires). 2008. PMID: 18786886 Spanish.
Chronic meningococcemia is an unfrequent clinical picture within the spectrum of infections produced by Neisseria meningitidis. ...It has been hypothesized that owing to high susceptibility to beta-lactam antibiotics of Neisseria meningitidis, many cases may
Chronic meningococcemia is an unfrequent clinical picture within the spectrum of infections produced by Neisseria menin
[Chronic meningococcemia].
de Boysson H, Deshayes S, Salmon-Rousseau A, Dubois A, Geffray L. de Boysson H, et al. Med Mal Infect. 2015 Jan-Feb;45(1-2):54-5. doi: 10.1016/j.medmal.2014.11.002. Epub 2014 Nov 14. Med Mal Infect. 2015. PMID: 25480454 French. No abstract available.
Chronic meningococcemia in a child with a deficiency of the sixth component of complement.
Fasano MB, Sullivan K, Ibsen L, Winkelstein JA. Fasano MB, et al. Pediatr Allergy Immunol. 1993 Nov;4(4):214-6. doi: 10.1111/j.1399-3038.1993.tb00094.x. Pediatr Allergy Immunol. 1993. PMID: 8298713 Review.
Chronic meningococcemia represents an uncommon manifestation of meningococcal disease. Microbial and host factors which may predispose to this form of meningococcal disease are not understood. Although acute meningococcal disease is frequently f
Chronic meningococcemia represents an uncommon manifestation of meningococcal disease. Microbial and host factors which
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C. Legendre CM, et al. N Engl J Med. 2013 Jun 6;368(23):2169-81. doi: 10.1056/NEJMoa1208981. N Engl J Med. 2013. PMID: 23738544 Free article. Clinical Trial.
BACKGROUND: Atypical hemolytic-uremic syndrome is a genetic, life-threatening, chronic disease of complement-mediated thrombotic microangiopathy. Plasma exchange or infusion may transiently maintain normal levels of hematologic measures but does not treat the underlying sy …
BACKGROUND: Atypical hemolytic-uremic syndrome is a genetic, life-threatening, chronic disease of complement-mediated thrombotic micr …
Ravulizumab (ALXN1210) vs eculizumab in adult patients with PNH naive to complement inhibitors: the 301 study.
Lee JW, Sicre de Fontbrune F, Wong Lee Lee L, Pessoa V, Gualandro S, Füreder W, Ptushkin V, Rottinghaus ST, Volles L, Shafner L, Aguzzi R, Pradhan R, Schrezenmeier H, Hill A. Lee JW, et al. Blood. 2019 Feb 7;133(6):530-539. doi: 10.1182/blood-2018-09-876136. Epub 2018 Dec 3. Blood. 2019. PMID: 30510080 Free PMC article. Clinical Trial.
Secondary end points were percent change from baseline in LDH, change from baseline in Functional Assessment of Chronic Illness Therapy (FACIT)-Fatigue score, proportion of patients with breakthrough hemolysis, stabilized hemoglobin, and change in serum free C5. ...The saf …
Secondary end points were percent change from baseline in LDH, change from baseline in Functional Assessment of Chronic Illness Thera …
Chronic meningococcemia.
GORE M. GORE M. Ann Intern Med. 1956 Jul;45(1):142-5. doi: 10.7326/0003-4819-45-1-142. Ann Intern Med. 1956. PMID: 13340577 No abstract available.
301 results